Is Regulus Therapeutics Inc. (NASDAQ: RGLS) Worth Your Money In 2021?

view original post

In the last trading session, 1.68 million shares of the Regulus Therapeutics Inc. (NASDAQ:RGLS) were traded, and its beta was 1.98. Most recently the company’s share price was $0.36, and it changed around $0.0 or 0.75% from the last close, which brings the market valuation of the company to $32.15M. RGLS currently trades at a discount to its 52-week high of $2.32, offering almost -544.44% off that amount. The share price’s 52-week low was $0.35, which indicates that the current value has risen by an impressive 2.78% since then. We note from Regulus Therapeutics Inc.’s average daily trading volume that its 3-month average coming to 1.96 million.

Regulus Therapeutics Inc. stock received a consensus recommendation rating of an Overweight, based on a mean score of 2.50. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended RGLS as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Regulus Therapeutics Inc. is expected to report earnings per share of -$0.08 for the current quarter.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Instantly RGLS has showed a green trend with a performance of 0.75% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4199 on Tuesday, 11/23/21 increased the stock’s daily price by 14.27%. The company’s shares are currently down -73.28% year-to-date, but still down -11.16% over the last five days. On the other hand, Regulus Therapeutics Inc. (NASDAQ:RGLS) is -18.94% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $1.17, which translates to bulls needing to increase their stock price by 69.23% from its current value. Analyst projections state that RGLS is forecast to be at a low of $0.50 and a high of $2.00. In order for the stock price to hit the forecast high, the stock would need to plunge -455.56% from its current level, while the stock would need to crash -38.89% from its current level to reach the projected low.

Regulus Therapeutics Inc. (RGLS) estimates and forecasts

Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will loss -100.00% in revenue this quarter, and will report a decrease of -133.30% in the next quarter. The year-over-year growth rate is expected to be -99.90%, down from the previous year.

The company’s sales for the same quarters a year ago were $340k and $5 million respectively.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 49.00%. Regulus Therapeutics Inc. earnings are expected to increase by 58.20% in 2021, but the outlook is positive 39.60% per year for the next five years.

RGLS Dividends

Regulus Therapeutics Inc.’s next quarterly earnings report is expected to be released around November 03 and November 08.

Regulus Therapeutics Inc. (NASDAQ:RGLS)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 4.26% of Regulus Therapeutics Inc. shares, and 37.67% of them are in the hands of institutional investors. The stock currently has a share float of 39.34%. Regulus Therapeutics Inc. stock is held by 50 institutions, with NEA Management Company, LLC being the largest institutional investor. By Jun 29, 2021, it held 7.41% of the shares, which is about 6.45 million shares worth $5.25 million.

Vanguard Group, Inc. (The), with 3.56% or 3.1 million shares worth $2.52 million as of Jun 29, 2021, holds the second largest percentage of outstanding shares.

>> 7 Top Picks for the Post-Pandemic Economy <<

Vanguard Total Stock Market Index Fund and Victory Portfolios-Victory RS Science & Technology Fund were the top two Mutual Funds as of Jun 29, 2021. The former held 1.85 million shares worth $1.5 million, making up 2.12% of all outstanding shares. On the other hand, Victory Portfolios-Victory RS Science & Technology Fund held roughly 1.77 million shares worth around $1.44 million, which represents about 2.03% of the total shares outstanding.